Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
11.91
-0.09 (-0.75%)
Dec 30, 2024, 11:46 AM EST - Market open
Palvella Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 3.42 | 3.08 | 4.16 |
| Research & Development | 4.22 | 8.79 | 13.88 |
| Operating Expenses | 7.64 | 11.87 | 18.04 |
| Operating Income | -7.64 | -11.87 | -18.04 |
| Interest Expense | -4.22 | - | -10.36 |
| Interest & Investment Income | - | 6.27 | - |
| Other Non Operating Income (Expenses) | 22.85 | 24.3 | -0.17 |
| Pretax Income | 11 | 18.69 | -28.58 |
| Income Tax Expense | - | - | -1.03 |
| Net Income | 11 | 18.69 | -27.55 |
| Preferred Dividends & Other Adjustments | 14.21 | 14.81 | - |
| Net Income to Common | -3.21 | 3.88 | -27.55 |
| Shares Outstanding (Basic) | 6 | 6 | 6 |
| Shares Outstanding (Diluted) | 6 | 6 | 6 |
| Shares Change (YoY) | - | 1.36% | - |
| EPS (Basic) | -0.56 | 0.68 | -4.82 |
| EPS (Diluted) | -0.56 | 0.67 | -4.82 |
| Free Cash Flow | -8.25 | -13.7 | -14.84 |
| Free Cash Flow Per Share | -1.44 | -2.36 | -2.59 |
| EBIT | -7.64 | -11.87 | -18.04 |
Source: S&P Capital IQ. Standard template.
Financial Sources.